As of 3:39pm ET
| -0.0025 / -0.53%|
The 1 analysts offering 12-month price forecasts for TapImmune Inc have a median target of 2.25, with a high estimate of 2.25 and a low estimate of 2.25. The median estimate represents a +376.19% increase from the last price of 0.47.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.